Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2020

Planlagt Fastgjort Låst Flyttet Genmab
767 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #448

    ja det vil være fint 🙂 nok bare træet der skal rystes inden CMD - vi er helt klart på et niveau det historisk har været godt at supplere på hvis vi skal forblive i nuværende kanal

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #449

      BofA ~ Sept Tepezza Symphony data provides reassurance on m/m growth outlook https://twitter.com/Quantumup1/status/1318687875005845519

      1 Reply Last reply
      0
      • A Offline
        A Offline
        AaBforever
        wrote on sidst redigeret af
        #450

        Så må vi jo håbe de ikke ryster træet så meget at det knækker;-)

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #451

          https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/87762_2216_gmab.JPG Så er vi ved 2216 niveau som ud fra TA ser interessandt ud afhængig om man vil ind i aktien eller hvis man har lidt for mange

          1 Reply Last reply
          0
          • D Offline
            D Offline
            Doublo
            wrote on sidst redigeret af
            #452

            StockBull vi er da på vej op synes jeg

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #453

              Darzalex salg for september var USD 234.6M, Faspro udgjorde 34%.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #454

                thanks Helge. SC growing fast... your source didn't have the Kesimpta number by any chance?

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #455

                  My source only has numbers for Darzalex.

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #456

                    Vi ser en 10% forøgelse i forhold til august.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #457

                      thanks. the % difference between real and prescription # isn't very constant...keeps bumping around between
                      ~13%-21.5%

                      1 Reply Last reply
                      0
                      • nohopeN Offline
                        nohopeN Offline
                        nohope
                        wrote on sidst redigeret af
                        #458

                        Begejstringen over tallet er begrænset.

                        1 Reply Last reply
                        0
                        • A Offline
                          A Offline
                          AaBforever
                          wrote on sidst redigeret af
                          #459

                          Da US åbnede 15.30 dykkede alle aktier.

                          1 Reply Last reply
                          0
                          • A Offline
                            A Offline
                            AaBforever
                            wrote on sidst redigeret af
                            #460

                            Eller rettere efter US åbning gik det nedad.

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #461

                              75 jobopslag vidner om god aktivitet https://genmab.wd3.myworkdayjobs.com/Genmab_Careers_Site

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #462

                                Mike Thompson, MD, PhD, FASCO
                                @mtmdphd
                                ·
                                3 min
                                #EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie
                                http://ow.ly/9Z2o30oEn9T
                                Activated: Apr 30, 2019 #mmsm @eaonc
                                #NCT03937635 cc @VincentRKhttps://twitter.com/mtmdphd/status/1318984444997500930

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  BioShare
                                  wrote on sidst redigeret af
                                  #463

                                  Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA - https://ml-eu.globenewswire.com/Resource/Download/b8ab2f2f-351e-4c85-b1ec-314bffbc3625

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    BioShare
                                    wrote on sidst redigeret af
                                    #464

                                    "...met the primary endpoint of
                                    improving progression free survival (PFS) at a pre-planned interim analysis (Hazard Ratio (HR) = 0.53
                                    (95% CI 0.42 – 0.68), p < 0.0001) resulting in a 47% reduction in the risk of progression or death in
                                    patients treated with daratumumab. The safety profile observed in this study was consistent with the
                                    known safety profile of daratumumab and no new safety signals were observed."

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #465

                                      Dejligt med første bevis og måske godkendelse i vedligeholdelsesbehandling -
                                      og lige tids nok til at de kan forsøge med en late breaker på ASH.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #466

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #467

                                          Genmab: Nye positive topdata med Darzalex i knoglemarvskræfthttps://www.proinvestor.com/investornyt/668859/genmab-nye-positive-topdata-med-darzalex-i-knoglemarvskraeft-gent

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger